3042 companies

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

AYR.A

CA$0.15

7D

0%

1Y

-93.6%

Biosergen

Market Cap: SEK 123.5m

A biotech company, develops antifungal products.

BIOSGN

SEK 0.53

7D

7.8%

1Y

-8.4%

atect

Market Cap: JP¥2.0b

Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses.

4241

JP¥445.00

7D

2.1%

1Y

-15.6%

Imunon

Market Cap: US$13.1m

A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.

IMNN

US$5.18

7D

4.0%

1Y

-61.8%

Vietnam Medicinal Materials

Market Cap: ₫343.5b

Produces and sells medicinal materials in Vietnam.

DVM

₫7,300.00

7D

0%

1Y

-17.2%

Gelteq

Market Cap: US$13.0m

Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.

GELS

US$1.40

7D

3.7%

1Y

n/a

OSR Holdings

Market Cap: US$13.0m

A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea.

OSRH

US$0.58

7D

-23.3%

1Y

-94.7%

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

PJ2

€3.80

7D

0%

1Y

-0.7%

Chemomab Therapeutics

Market Cap: US$12.9m

A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.

CMMB

US$2.64

7D

-0.4%

1Y

-57.1%

Indo-Bangla Pharmaceuticals

Market Cap: ৳1.6b

Engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.

IBP

৳13.50

7D

1.5%

1Y

27.4%

Mangalam Drugs & Organics

Market Cap: ₹1.1b

Together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.

532637

₹72.07

7D

-5.0%

1Y

-43.3%

Aptorum Group

Market Cap: US$12.8m

Through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.

APM

US$1.85

7D

3.9%

1Y

0%

Amwill Health Care

Market Cap: ₹1.1b

A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.

544353

₹56.38

7D

-4.4%

1Y

n/a

Verici Dx

Market Cap: UK£9.5m

Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.

VRCI

UK£0.0063

7D

-10.7%

1Y

-90.7%

Phio Pharmaceuticals

Market Cap: US$12.6m

A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.

PHIO

US$2.23

7D

7.7%

1Y

-36.3%

Polyrizon

Market Cap: US$12.6m

A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.

PLRZ

US$1.08

7D

-3.6%

1Y

n/a

Hemostemix

Market Cap: CA$17.5m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

HEM

CA$0.10

7D

-4.8%

1Y

0%

BLIS Technologies

Market Cap: NZ$21.7m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.

BLT

NZ$0.017

7D

0%

1Y

30.8%

Oxford BioDynamics

Market Cap: UK£9.3m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

OBD

UK£0.0047

7D

0%

1Y

-85.1%

NovaBay Pharmaceuticals

Market Cap: US$12.5m

Does not have significant operations.

NBY

US$2.19

7D

20.3%

1Y

208.5%

Valerio Therapeutics Société anonyme

Market Cap: €10.6m

A clinical-stage biotechnology company, designs and develops novel and first-in-class DNA-decoy therapies targeting proteins in tumors and inflammatory disease processes.

ALVIO

€0.058

7D

-0.3%

1Y

-25.4%

Cilo Cybin Holdings

Market Cap: R213.8m

Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide.

CCC

R3.01

7D

1.0%

1Y

-24.8%

PreveCeutical Medical

Market Cap: CA$17.1m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

PREV

CA$0.035

7D

0%

1Y

133.3%

TherapeuticsMD

Market Cap: US$12.3m

Operates as a pharmaceutical royalty company in the United States.

TXMD

US$1.07

7D

-1.8%

1Y

-34.8%

Zenith Drugs

Market Cap: ₹1.1b

Manufactures and trades in branded, generic, and OTC medicines.

ZENITHDRUG

₹63.00

7D

-2.2%

1Y

-55.4%

Intensity Therapeutics

Market Cap: US$12.2m

A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.

INTS

US$0.24

7D

-2.3%

1Y

-93.7%

Rize Oncology

Market Cap: US$12.1m

A biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications.

RZON.F

US$0.16

7D

0%

1Y

n/a

Advent Pharma

Market Cap: ৳1.4b

A pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh.

ADVENT

৳15.50

7D

0.6%

1Y

-22.1%

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally.

RWB

CA$0.035

7D

0%

1Y

-46.2%

Oncodesign Precision Medicine Société anonyme

Market Cap: €10.1m

A biopharmaceutical company, engages in the precision medicine business.

ALOPM

€0.55

7D

15.7%

1Y

-46.2%

Plant Advanced Technologies

Market Cap: €10.0m

A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.

ALPAT

€8.90

7D

-2.4%

1Y

-38.2%

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

NUMI

CA$0.05

7D

0%

1Y

-33.3%

Mustang Bio

Market Cap: US$11.6m

A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.

MBIO

US$1.59

7D

-4.8%

1Y

-86.2%

BioRestorative Therapies

Market Cap: US$11.6m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

BRTX

US$1.43

7D

-1.4%

1Y

-17.8%

Nanollose

Market Cap: AU$17.7m

A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.

NC6

AU$0.058

7D

-3.3%

1Y

205.3%

Sirona Biochem

Market Cap: CA$15.8m

A cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France.

SBM

CA$0.06

7D

0%

1Y

9.1%

Page 63 of 85